Hybrid optimal scheduling for intermittent androgen suppression of prostate cancer
From MaRDI portal
Publication:5251346
DOI10.1063/1.3526968zbMath1311.92103WikidataQ83094656 ScholiaQ83094656MaRDI QIDQ5251346
Kazuyuki Aihara, Yoshito Hirata, Nicholas Bruchovsky, Mario di Bernardo
Publication date: 20 May 2015
Published in: Chaos: An Interdisciplinary Journal of Nonlinear Science (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1063/1.3526968
90B35: Deterministic scheduling theory in operations research
37N25: Dynamical systems in biology
92C50: Medical applications (general)
Related Items
Nonlinear systems identification by combining regression with bootstrap resampling, Optimization therapy by coupling intermittent androgen suppression with impulsive chemotherapy for a prostate cancer model, A partial differential equation model and its reduction to an ordinary differential equation model for prostate tumor growth under intermittent hormone therapy, Global dynamics of a model of joint hormone treatment with dendritic cell vaccine for prostate cancer, Ability of intermittent androgen suppression to selectively create a non-trivial periodic orbit for a type of prostate cancer patients, Practically scheduling hormone therapy for prostate cancer using a mathematical model, The parameter Houlihan: a solution to high-throughput identifiability indeterminacy for brutally ill-posed problems, Optimal design of personalized prostate cancer therapy using infinitesimal perturbation analysis, Parameter estimation and optimal scheduling algorithm for a mathematical model of intermittent androgen suppression therapy for prostate cancer
Cites Work
- A nonlinear model with competition between prostate tumor cells and its application to intermittent androgen suppression therapy of prostate cancer
- Bifurcation analysis on a hybrid systems model of intermittent hormonal therapy for prostate cancer
- A mathematical model of intermittent androgen suppression for prostate cancer
- Piecewise affine systems modelling for optimizing hormone therapy of prostate cancer
- Mathematical modelling of prostate cancer growth and its application to hormone therapy
